Core Viewpoint - Catheter Precision, Inc. has received a new patent for its VIVO technology, enhancing its intellectual property portfolio and supporting its mission to improve non-invasive identification of ventricular arrhythmias [1][2]. Company Overview - Catheter Precision is a U.S.-based medical device company focused on developing innovative solutions for cardiac arrhythmias, emphasizing collaboration with physicians and continuous product advancement [4]. Product Information - VIVO (View Into Ventricular Onset) is a non-invasive 3D imaging system that helps physicians identify the origin of ventricular arrhythmias before procedures, thereby improving workflow and reducing procedure time. It has received marketing clearance from the U.S. FDA and holds the CE Mark [3]. Patent Significance - The newly granted patent titled "Methods of Ventricular Arrhythmia Localization Using a 3D Heart Model" allows the company to further advance its identification methods, providing essential information to physicians for successful patient treatment [1][2].
Catheter Precision Receives Notification of New Patent Issuance for VIVO Product Line